MedPath

SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients

Completed
Conditions
Sars-CoV2
Tear
Interventions
Diagnostic Test: Tears swab
Registration Number
NCT04402853
Lead Sponsor
Università degli Studi dell'Insubria
Brief Summary

Observational study to evaluate the presence of SARS COV-2 in tears collected in COVID-19 patients in Lombardia region, northern Italy, and to correlate virus presence to concomitant systemic clinical conditions.

Detailed Description

Since February 2020, Coronavirurus Disease 2019 associated to a severe acute respiratory syndrome started in China and rapidly spread all over the world and in particular in northern Italy. There are many reasons to justify this rapid diffusion in Italian Lombardia region as the high population density with more possibilities of interpersonal contact, high prevalence of respiratory pathologies, in particular in elderly people, due to pollution, high number of contacts with Chinese population for travelling and business reasons, and at last the non-windy temperate climate conditions, that increases the persistence of virus in the environment.

At now, more than eighty thousand citizens from Lombardia Region have been officially affected by the disease with a high death toll, also considering that actual numbers are certainly much underestimated.

The aim of the present study was to evaluate the prevalence of SARS COV-2 virus in tears collected from COVID-19 patients by rtPCR analysis directed to target sites of viral RNA, and to correlate virus presence to concomitant systemic clinical conditions

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Hospitalized COVID 19 patients
Exclusion Criteria
  • Patients with respiratory support that interferes with tears sampling

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COVID 19 PatientsTears swabhospitalized patients with COVID 19
Primary Outcome Measures
NameTimeMethod
Virus presence in COVID 19 patients tears1 day

prevalence of SARS CoV 2 virus on tears

Secondary Outcome Measures
NameTimeMethod
Concordance to Naso-Pharingeal Swab1 day

Evaluation of concordance with Naso-Pharingeal testing

Trial Locations

Locations (1)

ASST Sette Laghi

🇮🇹

Varese, Italy

© Copyright 2025. All Rights Reserved by MedPath